A co-development programme focused on an exosome-enabled hybrid scaffold for full-thickness wound repair, integrating polymeric scaffolds, dynamic hydrogels and biological signalling systems.
Imperion Biotechnology is contributing to a tissue-engineering co-development programme focused on an exosome-enabled hybrid scaffold for full-thickness wound repair.
The programme integrates an extrusion-manufactured polymeric scaffold, a dynamically cross-linked hydrogel phase and an exosome-enabled biological signalling system.
Imperion leads the biological product-development layer, with particular focus on exosome-system development, production strategy, functional incorporation into the scaffold architecture and translational positioning.